Myofibroblast-derived exosomes enhance macrophages to myofibroblasts transition and kidney fibrosis

References

• Eddy AA. Overview of the cellular and molecular basis of kidney fibrosis. Kidney Int Suppl (2011). 2014;4(1):1–15. doi: 10.1038/kisup.2014.2.
   PubMed Web of Science ®Google Scholar
• Huang R, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther. 2023;8(1):129.
   PubMed Web of Science ®Google Scholar
• Li L, Fu H, Liu Y. The fibrogenic niche in kidney fibrosis: components and mechanisms. Nat Rev Nephrol. 2022;18(9):545–557. doi: 10.1038/s41581-022-00590-z.
   PubMed Web of Science ®Google Scholar
• Ruiz-Ortega M, Rayego-Mateos S, Lamas S, et al. Targeting the progression of chronic kidney disease. Nat Rev Nephrol. 2020;16(5):269–288. doi: 10.1038/s41581-019-0248-y.
   PubMed Web of Science ®Google Scholar
• Xia X, Wang Y, Qin Y, et al. Exosome: a novel neurotransmission modulator or non-canonical neurotransmitter? Ageing Res Rev. 2022;74:101558. doi: 10.1016/j.arr.2021.101558.
   PubMed Web of Science ®Google Scholar
• Yang D, Zhang W, Zhang H, et al. Progress, opportunity, and perspective on exosome isolation – efforts for efficient exosome-based theranostics. Theranostics. 2020;10(8):3684–3707. doi: 10.7150/thno.41580.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Shin KJ, Jang H-J, et al. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis. Dev Cell. 2023;58(4):320–334.e8. doi: 10.1016/j.devcel.2023.01.006.
   PubMed Web of Science ®Google Scholar
• Tenchov R, Sasso JM, Wang X, et al. Exosomes—nature’s lipid nanoparticles, a rising star in drug delivery and diagnostics. ACS Nano. 2022;16(11):17802–17846. doi: 10.1021/acsnano.2c08774.
   PubMed Web of Science ®Google Scholar
• Chen S, Zhang M, Li J, et al. β-catenin-controlled tubular cell-derived exosomes play a key role in fibroblast activation via the OPN–CD44 axis. J Extracell Vesicles. 2022;11(3):e12203.
   PubMed Web of Science ®Google Scholar
• Chung YH, Huang GK, Kang CH, et al. MicroRNA-26a-5p restoration ameliorates unilateral ureteral obstruction-induced renal fibrosis in mice through modulating TGF-β signaling. Lab Invest. 2023;103(7):100131. doi: 10.1016/j.labinv.2023.100131.
   PubMed Web of Science ®Google Scholar
• Li D, Qu J, Yuan X, et al. Mesenchymal stem cells alleviate renal fibrosis and inhibit autophagy via exosome transfer of miRNA-122a. Stem Cells Int. 2022;2022:1981798. doi: 10.1155/2022/1981798.
   PubMed Web of Science ®Google Scholar
• LeBleu VS, Taduri G, O’Connell J, et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med. 2013;19(8):1047–1053. doi: 10.1038/nm.3218.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Portilla D, Okusa MD. Role of perivascular cells in kidney homeostasis, inflammation, repair and fibrosis. Nat Rev Nephrol. 2023;19(11):721–732. doi: 10.1038/s41581-023-00752-7.
   PubMed Web of Science ®Google Scholar
• Ranjan P, Kumari R, Goswami SK, et al. Myofibroblast-derived exosome induce cardiac endothelial cell dysfunction. Front Cardiovasc Med. 2021;8:676267. doi: 10.3389/fcvm.2021.676267.
   PubMed Web of Science ®Google Scholar
• Hu K, Wu C, Mars WM, et al. Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling. J Clin Invest. 2007;117(12):3821–3832. doi: 10.1172/JCI32301.
   PubMed Web of Science ®Google Scholar
• Tang PM, Nikolic-Paterson DJ, Lan HY. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15(3):144–158. doi: 10.1038/s41581-019-0110-2.
   PubMed Web of Science ®Google Scholar
• Liang H, Liu B, Gao Y, et al. Jmjd3/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosis. Front Immunol. 2022;13:978262. doi: 10.3389/fimmu.2022.978262.
   PubMed Web of Science ®Google Scholar
• Nikolic-Paterson DJ, Wang S, Lan HY. Macrophages promote renal fibrosis through direct and indirect mechanisms. Kidney Int Suppl (2011). 2014;4(1):34–38. doi: 10.1038/kisup.2014.7.
   PubMed Web of Science ®Google Scholar
• Wang Y-Y, Jiang H, Pan J, et al. Macrophage-to-myofibroblast transition contributes to interstitial fibrosis in chronic renal allograft injury. J Am Soc Nephrol. 2017;28(7):2053–2067. doi: 10.1681/ASN.2016050573.
   PubMed Web of Science ®Google Scholar
• Wei J, Xu Z, Yan X. The role of the macrophage-to-myofibroblast transition in renal fibrosis. Front Immunol. 2022;13:934377. doi: 10.3389/fimmu.2022.934377.
   PubMed Web of Science ®Google Scholar
• Chen J, Tang Y, Zhong Y, et al. P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition. Mol Ther. 2022;30(9):3017–3033. doi: 10.1016/j.ymthe.2022.06.019.
   PubMed Web of Science ®Google Scholar
• Tang PC-T, Chan AS-W, Zhang C-B, et al. TGF-β1 signaling: immune dynamics of chronic kidney diseases. Front Med. 2021;8:628519. doi: 10.3389/fmed.2021.628519.
   Google Scholar
• Zeng H, Gao Y, Yu W, et al. Pharmacological inhibition of STING/TBK1 signaling attenuates myeloid fibroblast activation and macrophage to myofibroblast transition in renal fibrosis. Front Pharmacol. 2022;13:940716. doi: 10.3389/fphar.2022.940716.
   PubMed Web of Science ®Google Scholar
• Ding H, Li LX, Harris PC, et al. Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease. Nat Commun. 2021;12(1):4548. doi: 10.1038/s41467-021-24799-x.
   PubMed Web of Science ®Google Scholar
• Zhou D, Fu H, Han Y, et al. Sonic hedgehog connects podocyte injury to mesangial activation and glomerulosclerosis. JCI Insight. 2019;4(22):e130515. doi: 10.1172/jci.insight.130515.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jia L, Hu Z, et al. AMP-activated protein kinase/myocardin-related transcription factor-A signaling regulates fibroblast activation and renal fibrosis. Kidney Int. 2018;93(1):81–94. doi: 10.1016/j.kint.2017.04.033.
   PubMed Web of Science ®Google Scholar
• Chinju A, Moriyama M, Kakizoe-Ishiguro N, et al. CD163+ M2 macrophages promote fibrosis in IgG4-related disease via toll-like receptor 7/interleukin-1 receptor-associated kinase 4/NF-κB signaling. Arthritis Rheumatol. 2022;74(5):892–901. doi: 10.1002/art.42043.
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Karim MR, Izawa T, et al. Immunophenotypical characterization of M1/M2 macrophages and lymphocytes in cisplatin-induced rat progressive renal fibrosis. Cells. 2021;10(2):257. doi: 10.3390/cells10020257.
   PubMed Web of Science ®Google Scholar
• Yin D, Cao J-Y, Yang Y, et al. Quercetin alleviates tubulointerstitial inflammation by inhibiting exosomes-mediated crosstalk between tubular epithelial cells and macrophages. Inflamm Res. 2023;72(5):1051–1067. doi: 10.1007/s00011-023-01730-2.
   PubMed Web of Science ®Google Scholar
• Liu X, Miao J, Wang C, et al. Tubule-derived exosomes play a central role in fibroblast activation and kidney fibrosis. Kidney Int. 2020;97(6):1181–1195. doi: 10.1016/j.kint.2019.11.026.
   PubMed Web of Science ®Google Scholar
• Zhao S, Li W, Yu W, et al. Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys. Theranostics. 2021;11(18):8660–8673. doi: 10.7150/thno.62820.
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhao S, Li W, et al. Tubular cell-derived exosomal miR-150-5p contributes to renal fibrosis following unilateral ischemia–reperfusion injury by activating fibroblast in vitro and in vivo. Int J Biol Sci. 2021;17(14):4021–4033. doi: 10.7150/ijbs.62478.
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. doi: 10.1126/science.aau6977.
   PubMed Web of Science ®Google Scholar
• Li C, Ni YQ, Xu H, et al. Roles and mechanisms of exosomal non-coding RNAs in human health and diseases. Signal Transduct Target Ther. 2021;6(1):383.
   PubMed Web of Science ®Google Scholar
• Vidal M. Exosomes: revisiting their role as "garbage bags". Traffic. 2019;20(11):815–828. doi: 10.1111/tra.12687.
   PubMed Web of Science ®Google Scholar
• Bai R, Li Y, Jian L, et al. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies. Mol Cancer. 2022;21(1):177. doi: 10.1186/s12943-022-01645-2.
   PubMed Web of Science ®Google Scholar
• Qian B, Yang Y, Tang N, et al. M1 macrophage-derived exosomes impair beta cell insulin secretion via miR-212-5p by targeting SIRT2 and inhibiting Akt/GSK-3β/β-catenin pathway in mice. Diabetologia. 2021;64(9):2037–2051. doi: 10.1007/s00125-021-05489-1.
   PubMed Web of Science ®Google Scholar
• Yan W, Li T, Yin T, et al. M2 macrophage-derived exosomes promote the c-KIT phenotype of vascular smooth muscle cells during vascular tissue repair after intravascular stent implantation. Theranostics. 2020;10(23):10712–10728. doi: 10.7150/thno.46143.
   PubMed Web of Science ®Google Scholar
• Zhou X, Brown BA, Siegel AP, et al. Exosome-mediated crosstalk between keratinocytes and macrophages in cutaneous wound healing. ACS Nano. 2020;14(10):12732–12748. doi: 10.1021/acsnano.0c03064.
   PubMed Web of Science ®Google Scholar
• Cheng F, Yang F, Wang Y, et al. Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating Yap/LOXL2 pathway. J Nanobiotechnol. 2023;21(1):195. doi: 10.1186/s12951-023-01942-y.
   PubMed Web of Science ®Google Scholar
• Feng Z, Jing Z, Li Q, et al. Exosomal STIMATE derived from type II alveolar epithelial cells controls metabolic reprogramming of tissue-resident alveolar macrophages. Theranostics. 2023;13(3):991–1009. doi: 10.7150/thno.82552.
   PubMed Web of Science ®Google Scholar
• Yuan J, Yang H, Liu C, et al. Microneedle patch loaded with exosomes containing microRNA-29b prevents cardiac fibrosis after myocardial infarction. Adv Healthc Mater. 2023;12(13):e2202959.
   PubMed Web of Science ®Google Scholar
• Gao Y, Yu W, Song J, et al. JMJD3 ablation in myeloid cells confers renoprotection in mice with DOCA/salt-induced hypertension. Hypertens Res. 2023;46(8):1934–1948. doi: 10.1038/s41440-023-01312-z.
   PubMed Web of Science ®Google Scholar
• Gao Y, Liu B, Guo X, et al. Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension. J Hypertens. 2023;41(5):794–810. doi: 10.1097/HJH.0000000000003401.
   PubMed Web of Science ®Google Scholar
• Antonia RJ, Hagan RS, Baldwin AS. Expanding the view of IKK: new substrates and new biology. Trends Cell Biol. 2021;31(3):166–178. doi: 10.1016/j.tcb.2020.12.003.
   PubMed Web of Science ®Google Scholar
• Brassington K, Kanellakis P, Cao A, et al. Crosstalk between cytotoxic CD8+ T cells and stressed cardiomyocytes triggers development of interstitial cardiac fibrosis in hypertensive mouse hearts. Front Immunol. 2022;13:1040233. doi: 10.3389/fimmu.2022.1040233.
   PubMed Web of Science ®Google Scholar
• Hao J, Huang X, Guan J, et al. Shenkang injection protects against renal fibrosis by reducing perforin expression through the STING/TBK1/IRF3 signaling pathways in natural killer cells. Phytomedicine. 2022;104:154206. doi: 10.1016/j.phymed.2022.154206.
   PubMed Web of Science ®Google Scholar
• Li M, Zhou Y, Wang T, et al. Nintedanib exerts anti-pulmonary fibrosis activity via inhibiting TANK-binding kinase 1 (TBK1) phosphorylation. Chem Commun. 2022;58(8):1199–1202. doi: 10.1039/d1cc05621b.
   PubMed Web of Science ®Google Scholar
• Occhigrossi L, Rossin F, Villella VR, et al. The STING/TBK1/IRF3/IFN type I pathway is defective in cystic fibrosis. Front Immunol. 2023;14:1093212. doi: 10.3389/fimmu.2023.1093212.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Q, Zhang X, et al. Recent advances in exosome-mediated nucleic acid delivery for cancer therapy. J Nanobiotechnol. 2022;20(1):279. doi: 10.1186/s12951-022-01472-z.
   PubMed Web of Science ®Google Scholar